West Pharmaceutical Services, Inc. WST
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.86% | 16.84% | 54.57% | 1.54% | 2.94% |
| Total Depreciation and Amortization | 6.74% | 11.59% | 13.00% | 15.48% | 6.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -522.31% | 22.50% | 1,860.00% | -130.95% | 202.50% |
| Change in Net Operating Assets | -1,019.05% | -1,997.56% | -103,000.00% | 247.66% | 2,200.00% |
| Cash from Operations | -3.90% | -29.98% | -30.53% | 32.09% | 9.49% |
| Capital Expenditure | 38.23% | 42.55% | 40.11% | 27.45% | 22.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 224.64% | 42.55% | 40.11% | 27.39% | 22.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -66.67% | -16,700.00% | -50.00% | -200.00% | 99.77% |
| Issuance of Common Stock | 62.50% | 69.23% | 70.45% | 48.39% | -33.33% |
| Repurchase of Common Stock | -232,200.00% | -31,240.00% | -120.66% | 99.63% | 99.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.65% | -3.97% | -3.95% | -3.27% | -4.14% |
| Other Financing Activities | -- | 80.95% | -- | 100.00% | -- |
| Cash from Financing | -2,002.61% | -1,006.04% | -110.00% | 83.02% | 82.14% |
| Foreign Exchange rate Adjustments | 147.22% | -108.65% | -198.82% | 97.80% | -132.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.18% | -181.14% | -235.70% | 2,684.13% | 165.77% |